Voyager Therapeutics, Inc. Increase (Decrease) in Restricted Cash
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-14
- Voyager Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was -$50.00K.
- Voyager Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- Voyager Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-06-30 was $0.00.
- Voyager Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-03-31 was $471.00K.
- Voyager Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2016 was $421.00K.
- Voyager Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2014 was $314.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$50.00K derived: sum of 2 quarters · filed 2018-03-14 | -$50.00K derived: sum of 3 quarters · filed 2018-03-14 | $421.00K 10-K · filed 2018-03-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $471.00K 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $471.00K 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $471.00K 10-Q · filed 2017-05-09 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $314.00K 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $314.00K 10-Q · filed 2015-12-17 |